DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Develops, produces, and markets human medicines, APIs, and veterinary drugs globally.

DEVA | IS

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte

Description

Established in 1958, DEVA Holding A.Ş. is a pharmaceutical company focused on the development, production, and marketing of medicinal products for human use and active pharmaceutical ingredients (APIs). The company also produces veterinary drugs. DEVA Holding maintains a diverse product portfolio, which includes antineoplastic and immunomodulating agents, and makes its products available on a global scale. Its international business operations are managed through various models, including distributorships, out-licensing, and direct supply agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-17 20:36
Board of Directors recommendation regarding operating profit for 2023
Turkish 552.0 KB
2024-05-17 20:36
Board of Directors recommendation regarding operating profit for 2023
Turkish 242.1 KB
2024-05-17 20:36
Board of Directors recommendation regarding operating profit for 2023
Turkish 38.8 KB
2024-05-17 20:26
Decision of the Board of Directors on the Ordinary General Assembly Meeting
Turkish 10.5 KB
2024-05-17 20:19
Sustainability Principles Compliance Statement
Turkish 321.7 KB
2024-05-17 20:19
2023 Corporate Governance Information Form
Turkish 347.4 KB
2024-05-17 20:17
Corporate Governance Compliance Report
Turkish 390.8 KB
2024-05-17 20:15
Declaration of Responsibility
Turkish 28.0 KB
2024-05-17 20:14
Financial Report
Turkish 1.1 MB
2024-05-17 20:14
Financial Report
English 2.5 MB
2024-05-17 20:13
Annual Report
Turkish 3.8 MB
2024-05-17 20:13
Annual Report
Turkish 3.9 MB
2024-05-17 20:13
Annual Report
Turkish 13.4 KB
2024-05-13 13:32
Investment Incentive Certificate period extension
Turkish 19.9 KB
2024-05-09 18:28
Determination of Independent Audit Company
Turkish 31.2 KB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.